Birth Complications and Intrauterine Constraints in the Etiology of Congenital Muscular Torticollis: A Nationwide Registry Study

NCT ID: NCT06901414

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-26

Study Completion Date

2024-11-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective register-based cohort study investigates the association between birth complications, intrauterine crowding, and the development of congenital muscular torticollis (CMT). CMT is characterized by the shortening and tightening of the sternocleidomastoid muscle, leading to abnormal head positioning. The study will analyze data from the Norwegian Medical Birth Registry (MFR) and the Norwegian Patient Registry (NPR) to determine whether individuals with CMT have a higher prevalence of birth complications or signs of intrauterine crowding compared to the general population. By identifying risk factors associated with CMT, this study aims to identify the possible etiology of CMT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Congenital Muscular Torticollis (CMT) is a condition affecting infants, characterized by a shortened and tightened sternocleidomastoid muscle (SCM), resulting in abnormal head positioning. Despite various theories, the exact etiology of CMT remains unclear. Two primary hypotheses include birth trauma and intrauterine crowding. Some studies have suggested an association between CMT and operative deliveries, whereas others have found no such association. Similarly, intrauterine crowding, such as in multiple pregnancies, has been proposed as a contributing factor due to mechanisms like ischemia or compartment syndrome.

While most children with CMT experience a mild condition that resolves with stretching and physiotherapy, a notable overrepresentation of complicated deliveries has been observed among patients requiring surgical intervention for CMT. This study aims to further explore these hypotheses by analyzing data from the Norwegian Medical Birth Registry (MFR).

Study Objectives The primary objective of this study is to compare the prevalence of operative deliveries and indicators of intrauterine crowding between individuals diagnosed with CMT and the general population. The study seeks to determine whether complicated deliveries and/or crowding are overrepresented among patients with CMT. Specifically, the study will investigate whether there is an increased occurrence of restricted intrauterine conditions or operative deliveries in CMT patients compared to the general birth cohort. If a significant association is found, it would support the hypothesis that these factors contribute to the development of CMT.

Expected Outcomes By conducting this study, we expect to contribute to a better understanding of the potential causes of CMT. The findings may improve early identification and potentially influence obstetric and neonatal management strategies.

Methods This is a registry-based study utilizing anonymized data from the Norwegian Patient Registry (NPR) and linking it to the MFR. The study will identify a cohort of individuals diagnosed with CMT and a matched control group (1:4) from the general population.

Study Design Type: Retrospective, cohort, observational, registry-based study. Matching: Cases will be matched with controls based on birth year, sex, and gestational age at birth in a 1:4 ratio.

Population: Patients diagnosed with CMT who have undergone surgery in Norway, born between 1990 and 2023, will be identified using ICD-10 code Q68.0 and procedure codes NAL39/NAL69/NAL99.

Variables

The study will collect data on variables relevant to birth trauma and crowding hypotheses:

Birth Trauma Indicators:

* Mode of delivery (spontaneous vaginal delivery, assisted vaginal delivery, cesarean section)
* Shoulder dystocia indicators (clavicle fracture, brachial plexus injury)
* Birth weight (\>4000g, macrosomia)
* Breech presentation (vaginal delivery)
* Vacuum-assisted delivery
* Forceps-assisted delivery
* Emergency cesarean section due to mechanical complications
* Indications for cesarean section (maternal or fetal factors)

Crowding Indicators:

* Multiple pregnancies (number of fetuses per pregnancy)
* Amniotic fluid levels (normal vs. polyhydramnios)
* Fetal position at birth (cephalic, breech, transverse)
* Birth weight and length relative to gestational age
* Gestational duration (preterm, full-term, post-term)
* Maternal height
* Birth order (firstborn vs. later-born)

Data Collection Data will be retrieved from MFR and NPR through Helsedata.no. The collected data will be anonymized to ensure compliance with ethical guidelines.

Statistical Analysis

The study will employ appropriate statistical methods to compare the prevalence of the examined variables between the CMT cohort and the control group:

* Descriptive statistics to summarize demographic and clinical variables.
* Univariate analysis (Chi-square or Fisher's exact test) to compare the frequency of complicated deliveries between groups.
* Multivariate logistic regression analysis to adjust for confounding variables, including maternal age, comorbidities, gestational age, birth weight, and delivery method.
* Directed Acyclic Graphs (DAGs) will be utilized to illustrate causal relationships.

Limitations

* Potential limitations in available data from MFR.
* Retrospective study design with possible missing or incomplete data.
* The need to differentiate between the causality of crowding and operative delivery, as crowding may necessitate operative delivery.
* Variability in delivery methods across hospitals.
* Selection bias in operative deliveries due to pre-existing intrauterine conditions.

Ethical Considerations Ethical approval will be obtained from the Regional Committees for Medical and Health Research Ethics (REK) and the local privacy protection officer (PVO) at Vestre Viken. The study will use de-identified registry data to maintain participant confidentiality. There will be no direct patient involvement, ensuring compliance with ethical standards.

This study is expected to provide significant insights into the etiology of CMT, contributing to better prevention and management strategies for affected individuals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Muscular Torticollis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CMT cases

Children identified in the Norwegian Patient Registry (NPR) with the diagnosis of congenital muscular torticollis (ICD-10 Q68.0) born between 1990 and 2023

No interventions assigned to this group

Matched control group

Consisting of individuals from the general population, matched in a 1:4 ratio based on birth year, sex, and gestational age at birth.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals diagnosed with congenital muscular torticollis (ICD-10 code: Q68.0) and registered in the Norwegian Patient Registry (NPR).
* Born in Norway after 1990
* Underwent surgical treatment for CMT (procedure codes NAL39/NAL69/NAL99).

Exclusion Criteria

* Individuals with incomplete birth registry data in the MFR.
* Presence of congenital anomalies unrelated to CMT that could confound study outcomes.
* Cases with missing gestational age, birth weight, or delivery method.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vestre Viken Hospital Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vestre Viken HF

Drammen, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMT Etiology

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.